Hemex Health Raises $2.5M for Global Health Diagnostics

Hemex Health, Inc. today announced it has successfully secured $2,500,000 in new investment capital from investors. This funding round marks a significant milestone for the company as it progresses its mission to enhance global health diagnostics and make crucial medical tools more accessible. Hemex Health is dedicated to commercializing proven research into cost-effective, intuitive devices optimized for front-line healthcare. Its products are designed for ease of use, providing quick and effective benefits for healthcare workers and patients at the point-of-need, particularly in low-resource settings. The company is notably developing a diagnostic platform, which utilizes technology recognized with a 2016 Patents for Humanity Award. This platform can quickly and accurately diagnose hemoglobin disorders, such as sickle cell disease and beta thalassemia, from a single drop of blood, offering a point-of-care solution that is faster, more cost-effective, and more accurate than existing market alternatives. The newly raised capital is intended to support Hemex Health’s ongoing growth initiatives, including further development and refinement of its diagnostic technologies and scaling commercialization efforts. This investment underscores confidence in the company’s vision and its leadership, which comprises individuals with backgrounds in international business and biomedical engineering, boasting decades of success in developing and delivering over 60 medical products with global impact. Their experience is central to addressing major needs in global health through innovative, low-cost technologies. With this substantial funding, Hemex Health is poised to expand the availability of its essential diagnostic solutions worldwide. The company remains focused on its commitment to delivering accessible and effective diagnostic tools, aiming to positively impact millions of lives by facilitating the early identification of diseases that can be affordably treated, thereby improving health outcomes in underserved populations.